Esophageal cancer carries a five-year survival of approximately 22% — one of the lowest of any solid tumor — with 22,530 new cases and 16,290 deaths projected in the United States in 2026. The median age at diagnosis is 69. Most cases are caught late, and the reason is familiar: dysphagia, heartburn, and hoarseness are attributed to GERD and managed with PPI escalation rather than endoscopy. Up to 40% of esophageal adenocarcinoma patients never had classic reflux symptoms. Dysphagia is an alarm signal. It warrants EGD, not a medication adjustment.
AAVBC's Esophageal Cancer Quick Reference Guide provides primary care clinicians with a practical reference for a cancer where recognition speed determines outcomes. It covers histologic subtype differentiation, Barrett's esophagus surveillance and dysplasia grading, ICD-10 subsite coding, alarm symptom thresholds, metastatic site documentation, and MEAT documentation standards — grounded in current NCCN and ACG guideline evidence.
AAVBC’s Deep-Dive series offers a comprehensive, structured analysis of esophageal cancer — moving far beyond quick-reference essentials. These guides provide an integrated review of epidemiology, diagnostic strategy, staging, coding logic, MEAT-aligned documentation examples, treatment guidelines, review vulnerabilities, and cost-utilization considerations. The Deep-Dive combines evidence-informed clinical guidance with practical operational tools to support a deeper understanding of disease complexity and provide multidisciplinary teams with strategies to thrive within value-based frameworks.
Esophageal cancer carries a five-year survival of approximately 22% — one of the lowest of any solid tumor — with 22,530 new cases and 16,290 deaths projected in the United States in 2026. The median age at diagnosis is 69. Most cases are caught late, and the reason is familiar: dysphagia, heartburn, and hoarseness are attributed to GERD and managed with PPI escalation rather than endoscopy. Up to 40% of esophageal adenocarcinoma patients never had classic reflux symptoms. Dysphagia is an alarm signal. It warrants EGD, not a medication adjustment.
AAVBC's Esophageal Cancer Quick Reference Guide provides primary care clinicians with a practical reference for a cancer where recognition speed determines outcomes. It covers histologic subtype differentiation, Barrett's esophagus surveillance and dysplasia grading, ICD-10 subsite coding, alarm symptom thresholds, metastatic site documentation, and MEAT documentation standards — grounded in current NCCN and ACG guideline evidence.
AAVBC’s Deep-Dive series offers a comprehensive, structured analysis of esophageal cancer — moving far beyond quick-reference essentials. These guides provide an integrated review of epidemiology, diagnostic strategy, staging, coding logic, MEAT-aligned documentation examples, treatment guidelines, review vulnerabilities, and cost-utilization considerations. The Deep-Dive combines evidence-informed clinical guidance with practical operational tools to support a deeper understanding of disease complexity and provide multidisciplinary teams with strategies to thrive within value-based frameworks.
